Hideki Hasegawa

InstitutionNational Institute of Infectious Diseases
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 1 publications in April 2020 and June 2020 and July 2020 and Spetember 2020 and November 2020 and February 2021 and March 2021 and May 2021 and July 2021 and December 2021
    All Publications
    Bar chart showing 210 publications over 20 distinct years, with a maximum of 23 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Funabashi R, Miyakawa K, Yamaoka Y, Yoshimura S, Yamane S, Jeremiah SS, Shimizu K, Ozawa H, Kawakami C, Usuku S, Tanaka N, Yamazaki E, Kimura H, Hasegawa H, Ryo A. Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor. J Mol Cell Biol. 2021 12 30; 13(10):763-766. PMID: 34165565.
      Citations:    Fields:    Translation:Humans
    2. Hasegawa H. Development of Corona-virus-disease-19 Vaccines. JMA J. 2021 Jul 15; 4(3):187-190. PMID: 34414311.
      Citations:    
    3. Yamaoka Y, Miyakawa K, Jeremiah SS, Funabashi R, Okudela K, Kikuchi S, Katada J, Wada A, Takei T, Nishi M, Shimizu K, Ozawa H, Usuku S, Kawakami C, Tanaka N, Morita T, Hayashi H, Mitsui H, Suzuki K, Aizawa D, Yoshimura Y, Miyazaki T, Yamazaki E, Suzuki T, Kimura H, Shimizu H, Okabe N, Hasegawa H, Ryo A. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests. Cell Rep Med. 2021 06 15; 2(6):100311. PMID: 34027498.
      Citations: 3     
    4. Takashita E, Kawakami C, Momoki T, Saikusa M, Shimizu K, Ozawa H, Kumazaki M, Usuku S, Tanaka N, Okubo I, Morita H, Nagata S, Watanabe S, Hasegawa H, Kawaoka Y. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza Other Respir Viruses. 2021 07; 15(4):488-494. PMID: 33715290.
      Citations: 14     Fields:    Translation:HumansCells
    5. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T, Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada K, Fujita R, Saito H, Okinaka K, Griffith M, Parry AE, Barnetson B, Leonard J, Wakita T. Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship. J Infect Dis. 2021 02 13; 223(3):540. PMID: 32905593.
      Citations:    Fields:    
    6. Miyakawa K, Jeremiah SS, Ohtake N, Matsunaga S, Yamaoka Y, Nishi M, Morita T, Saji R, Nishii M, Kimura H, Hasegawa H, Takeuchi I, Ryo A. Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles. J Mol Cell Biol. 2020 11 25; 12(12):987-990. PMID: 32931563.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T, Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada K, Fujita R, Saito H, Okinaka K, Griffith M, Parry AE, Barnetson B, Leonard J, Wakita T. Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship. J Infect Dis. 2020 09 01; 222(7):1098-1102. PMID: 32691828.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    8. Sekizuka T, Itokawa K, Kageyama T, Saito S, Takayama I, Asanuma H, Nao N, Tanaka R, Hashino M, Takahashi T, Kamiya H, Yamagishi T, Kakimoto K, Suzuki M, Hasegawa H, Wakita T, Kuroda M. Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak. Proc Natl Acad Sci U S A. 2020 08 18; 117(33):20198-20201. PMID: 32723824.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    9. Arima Y, Shimada T, Suzuki M, Suzuki T, Kobayashi Y, Tsuchihashi Y, Nakamura H, Matsumoto K, Takeda A, Kadokura K, Sato T, Yahata Y, Nakajima N, Tobiume M, Takayama I, Kageyama T, Saito S, Nao N, Matsui T, Sunagawa T, Hasegawa H, Ohnishi M, Wakita T. Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020. Emerg Infect Dis. 2020 07; 26(7). PMID: 32275498.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    10. Okamaoto K, Shirato K, Nao N, Saito S, Kageyama T, Hasegawa H, Suzuki T, Matsuyama S, Takeda M. Assessment of Real-Time RT-PCR Kits for SARS-CoV-2 Detection. Jpn J Infect Dis. 2020 Sep 24; 73(5):366-368. PMID: 32350226.
      Citations: 15     Fields:    Translation:HumansCells
    11. Sekimukai H, Iwata-Yoshikawa N, Fukushi S, Tani H, Kataoka M, Suzuki T, Hasegawa H, Niikura K, Arai K, Nagata N. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. Microbiol Immunol. 2020 Jan; 64(1):33-51. PMID: 31692019.
      Citations: 42     Fields:    Translation:AnimalsCellsPHPublic Health
    12. Iwata-Yoshikawa N, Okamura T, Shimizu Y, Kotani O, Sato H, Sekimukai H, Fukushi S, Suzuki T, Sato Y, Takeda M, Tashiro M, Hasegawa H, Nagata N. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus. J Virol. 2019 03 15; 93(6). PMID: 30626685.
      Citations: 22     Fields:    Translation:AnimalsCells
    13. Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. J Virol. 2019 03 15; 93(6). PMID: 30626688.
      Citations: 248     Fields:    Translation:HumansAnimalsCells
    14. Iwata-Yoshikawa N, Fukushi S, Fukuma A, Suzuki T, Takeda M, Tashiro M, Hasegawa H, Nagata N. Non Susceptibility of Neonatal and Adult Rats against the Middle East Respiratory Syndrome Coronavirus. Jpn J Infect Dis. 2016 Nov 22; 69(6):510-516. PMID: 27000459.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    15. Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, Tashiro M, Sata T, Hasegawa H, Nagata N. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol. 2014 Aug; 88(15):8597-614. PMID: 24850731.
      Citations: 54     Fields:    Translation:AnimalsCells
    16. Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol. 2014 May; 88(10):5608-16. PMID: 24600012.
      Citations: 67     Fields:    Translation:AnimalsCells
    17. Ishii K, Hasegawa H, Nagata N, Ami Y, Fukushi S, Taguchi F, Tsunetsugu-Yokota Y. Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. Microbiol Immunol. 2009 Feb; 53(2):75-82. PMID: 19291090.
      Citations: 11     Fields:    Translation:AnimalsCells
    18. Nagata N, Iwata N, Hasegawa H, Fukushi S, Harashima A, Sato Y, Saijo M, Taguchi F, Morikawa S, Sata T. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol. 2008 Jun; 172(6):1625-37. PMID: 18467696.
      Citations: 52     Fields:    Translation:HumansAnimalsCells
    19. Nagata N, Iwata N, Hasegawa H, Sato Y, Morikawa S, Saijo M, Itamura S, Saito T, Ami Y, Odagiri T, Tashiro M, Sata T. Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. Int J Exp Pathol. 2007 Dec; 88(6):403-14. PMID: 18039277.
      Citations: 6     Fields:    Translation:AnimalsCells
    20. Nagata N, Iwata N, Hasegawa H, Fukushi S, Yokoyama M, Harashima A, Sato Y, Saijo M, Morikawa S, Sata T. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol. 2007 Feb; 81(4):1848-57. PMID: 17151094.
      Citations: 30     Fields:    Translation:AnimalsCells
    21. Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Suzuki T, Taguchi F, Tashiro M, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. Virology. 2006 Aug 01; 351(2):368-80. PMID: 16678878.
      Citations: 10     Fields:    Translation:AnimalsCells
    22. Nagata N, Iwata N, Hasegawa H, Asahi-Ozaki Y, Sato Y, Harashima A, Morikawa S, Saijo M, Itamura S, Saito T, Odagiri T, Tashiro M, Ami Y, Sata T. Pathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals. Adv Exp Med Biol. 2006; 581:515-8. PMID: 17037588.
      Citations:    Fields:    Translation:AnimalsCells
    23. Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Tashiro M, Suzuki T, Taguchi F, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Highly attenuated vaccinia virus DIs as a potential SARS vaccine. Adv Exp Med Biol. 2006; 581:593-6. PMID: 17037603.
      Citations:    Fields:    Translation:HumansAnimalsCells
    24. Saijo M, Morikawa S, Fukushi S, Mizutani T, Hasegawa H, Nagata N, Iwata N, Kurane I. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. Antiviral Res. 2005 Jun; 66(2-3):159-63. PMID: 15911031.
      Citations: 34     Fields:    Translation:AnimalsCells